「head」の検索結果
21件：11～15件目を表示
もしかして
-
24 Senju Pharmaceutical Co., Ltd. Launch of Distribution of RET-700 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the...
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240726_0.pdf -
24 Senju Pharmaceutical Co., Ltd. Launch of Distribution of RET-700 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the...
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240726.pdf -
Company Profile | About Senju | SENJU Pharmaceutical
Corporate Name Senju Pharmaceutical Co.,Ltd. Headquarter 3-1-9, Kawara-machi, Chuo-ku, Osaka 541-0048,Japan TEL：+81-6-6201-2512 FAX：+81-6-6226-0406 Date of Incorporation April 9, 1947 Capital 1,415,50...
http://www.senju.co.jp/english/about/outline.html -
Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1...
https://www.senju.co.jp/sites/default/files/content_news/2025-01/ENG_20250117_0.pdf -
ls use a novel compound discovered by Mochida and licensed to Senju Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) and Mochida Pharmaceu...
https://www.senju.co.jp/sites/default/files/content_news/2023-03/ENG_20230322.pdf